Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2026-02-07 @ 7:05 AM
Study NCT ID:
NCT04560166
Status:
TERMINATED
Last Update Posted:
2024-03-18
First Post:
2020-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
Sponsor:
Y-mAbs Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neuroblastoma Recurrent | View |
Keywords: